Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT05763420

Sealer-Based Obturation With AH Plus Bioceramic Sealer vs. Warm Vertical Compaction With AH Plus

The goal of this clinical trial is to assess the efficacy and outcome of sealer-based obturation (SBO) using a new calcium silicate sealer in comparison with warm vertical compaction (WVC) using a resin-based sealer, which is the current gold standard.

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Jaber Al-Ahmed Dental Center

Janūb as Surrah, Hawalli Governate, 00000, Kuwait

About this study

Calcium silicate sealers are used in endodontics because of their biocompatibility, bioactivity, and their ability to form a hydroxyapatite-mediated interfacial bond with root canal dentine. Although in vitro and retrospective clinical studies have reported promising findings, there remains a lack of prospective, well-controlled trials evaluating their clinical and radiographic performance.

Aims and Objectives:

  • To compare the clinical outcome of single-cone bioceramic obturation (SBO) with warm vertical compaction (WVC) in primary root canal treatment.
  • To compare the radiographic outcome of SBO and WVC using periapical (PA) radiographs and cone-beam computed tomography (CBCT).

Materials and Methods:

Patients referred for primary root canal treatment of molar teeth at Jaber Al-Ahmed Dental Center who fulfil the inclusion and exclusion criteria will be invited to participate. Written informed consent will be obtained from all participants.

Preoperative PA radiographs and CBCT scans will be taken. After completion of root canal instrumentation, participants will be randomly allocated to either Group A: SBO or Group B: WVC. Participants will be blinded to the obturation technique. Allocation will remain concealed until canals are ready for obturation, at which time the treating clinician will be informed of the assigned method.

All teeth will receive definitive restorations following obturation. Participants will be recalled at 12-24 months for clinical and radiographic evaluation using PA radiographs and CBCT, and will subsequently be followed annually for up to 5 years.

The study will conform to the CONSORT statement and will be conducted in accordance with the Declaration of Helsinki. Ethical approval has been granted by the local health authority (ID: 2291).

Statistical and Analytical Plan:

The sample size was determined for a non-inferiority comparison of the primary success proportion between the treatment group (AH Plus Bioceramic Sealer) and the reference group. Assuming a reference-group success proportion of 92%, a non-inferiority margin of 13 percentage points (δ₀ = -0.13), and no true difference between groups under the alternative hypothesis (δ₁ = 0), a one-sided, two-sample Z-test with unpooled variance at a significance level of 0.05 required 54 evaluable participants per group (108 in total) to achieve 80% power. To account for an anticipated attrition rate of 30%, the enrollment target was inflated to 78 participants per group (156 in total), applying the formula N' = N / (1 - 0.30). All calculations were performed using PASS (NCSS, LLC, Kaysville, UT, USA).

Healing at 12-24 months will serve as the dependent variable in logistic regression models. Predictor variables will include age, sex, preoperative status, presence of apical periodontitis, preoperative pain, patency, apical preparation size, root filling quality, and sealer type. Two-way interactions will be assessed. Analyses will follow the intention-to-treat principle.

Null Hypothesis:

H₀: There is no difference between SBO and WVC in clinical or radiographic healing outcomes at 12-24 months.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Participants must be 18-65 years of age at the time of recruitment
  • Participants must have a classification of I or II on the American Society of Anesthesiologists (ASA) physical status classification system
  • Participants must not have known allergies to any materials used in the study
  • Participants must agree to participate in the study by signing a consent form
  • Participants must have good oral hygiene
  • Maxillary and mandibular permanent molar teeth that require primary root canal treatment will be included
  • The teeth must be restorable and have fully formed roots with no advanced periodontal disease

Exclusion criteria

  • ASA classification of III or more
  • Pregnant or breastfeeding women
  • Patients who are unable to give consent
  • Patients who have advanced periodontal disease or teeth with more than 5mm probing
  • Anterior, premolar and third molar teeth
  • Teeth whose apices were over-enlarged at the time of pulp extirpation
  • Teeth with broken instruments
  • Teeth with blocked or non-negotiable canals
  • Teeth with iatrogenic perforations
  • Teeth with incomplete root formation
  • Teeth with internal or external root resorption
  • Teeth that have a poor restorative prognosis
  • Teeth that require posts or extensive prosthetic rehabilitation
  • Teeth with cracks
  • Teeth that have been previously root-filled

Treatment and study plan

AH Plus Bioceramic Sealer

Device

A bioactive, calcium silicate-based sealer will be used in combination with the core root canal filling material (gutta-percha). It's premixed and is dispensed in the root canal via a fine disposable syringe.

AH Plus Sealer (resin-based)

Device

A resin-based sealer will be used in combination with the core root canal material (gutta-percha). It consists of two pastes that are mixed together in equal amounts prior to application.

Primary outcomes

  1. Assessment of radiographic healing with cone beam computed tomography (CBCT) scans using Estrela's PAI (periapical index)

    Time frame: Change from baseline periapical lesion size at 12-24 months

    Estrela's PAI based on CBCT will be used in logistic regression models with different predictor variables.

  2. Assessment of clinical outcome by assessing the resolution/persistence/development of clinical signs and symptoms

    Time frame: Change from baseline at 12-24 months

    The examiner will label the teeth as having a normal clinical outcome (absence of pain, swelling and other symptoms, no sinus tract, no loss of function) or showing signs and symptoms clinical outcome (the tooth is associated with signs and/or symptoms of infection).

Sponsors and collaborators

Lead sponsor

Ministry of Health, Kuwait

Other Gov

Collaborators

  • Kuwait Institute for Medical Specialization

Registry information

Official study title

Outcome of Sealer-Based Obturation With AH Plus Bioceramic Sealer Versus Warm Vertical Compaction With AH Plus: A CBCT-Based Randomized Controlled Trial

Important dates

Study start
2023
Primary completion
2026
Study completion
2027
First posted
Mar 10, 2023
Registry last updated
Jul 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.